Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

ANTIVIRAL COMPOSITIONS CONTAINING SULFOQUINOVOSYL GLYCEROL DERIVATIVES AND ANALOGS THEROF AND METHODS FOR USING SAME

  • Read more about ANTIVIRAL COMPOSITIONS CONTAINING SULFOQUINOVOSYL GLYCEROL DERIVATIVES AND ANALOGS THEROF AND METHODS FOR USING SAME
Switzerland
90911686.5
Filed on 1990-08-03

EFFICIENT DIRECTIONAL GENETIC CLONING SYSTEM

  • Read more about EFFICIENT DIRECTIONAL GENETIC CLONING SYSTEM
Canada
2064092
Filed on 1990-07-30

EFFICIENT DIRECTIONAL GENETIC CLONING SYSTEM

  • Read more about EFFICIENT DIRECTIONAL GENETIC CLONING SYSTEM
Australia
61879/90
Filed on 1990-07-30

DNA ENCODING A GROWTH FACTOR SPECIFIC FOR EPITHELIAL CELLS (KGF)

  • Read more about DNA ENCODING A GROWTH FACTOR SPECIFIC FOR EPITHELIAL CELLS (KGF)
Japan
285517/99
Filed on 1990-01-30

Method of Preparing an Active Human Neutrophil Chemotactic Factor Polypeptide

  • Read more about Method of Preparing an Active Human Neutrophil Chemotactic Factor Polypeptide
Luxembourg
89909925.3
Filed on 1989-08-29

Method of Preparing an Active Human Neutrophil Chemotactic Factor Polypeptide

  • Read more about Method of Preparing an Active Human Neutrophil Chemotactic Factor Polypeptide
Belgium
89909925.3
Filed on 1989-08-29

METHOD FOR EARLY DETECTION OF LUNG CANCER

  • Read more about METHOD FOR EARLY DETECTION OF LUNG CANCER
Japan
10-87822
Filed on 1989-03-09

METHOD TO PREDICT ANTIGENIC SITE RECOGNIZED BY T-LYMPHO-CYTES SUCH AS FOR DESIGN OF VACCINES

  • Read more about METHOD TO PREDICT ANTIGENIC SITE RECOGNIZED BY T-LYMPHO-CYTES SUCH AS FOR DESIGN OF VACCINES
Japan
63-501340
Filed on 1987-12-23

METHOD TO PREDICT ANTIGENIC SITE RECOGNIZED BY T-LYMPHO-CYTES SUCH AS FOR DESIGN OF VACCINES

  • Read more about METHOD TO PREDICT ANTIGENIC SITE RECOGNIZED BY T-LYMPHO-CYTES SUCH AS FOR DESIGN OF VACCINES
European Patent
87311524.0
Filed on 1987-12-30

METHOD TO PREDICT ANTIGENIC SITE RECOGNIZED BY T-LYMPHO-CYTES SUCH AS FOR DESIGN OF VACCINES

  • Read more about METHOD TO PREDICT ANTIGENIC SITE RECOGNIZED BY T-LYMPHO-CYTES SUCH AS FOR DESIGN OF VACCINES
Canada
555482
Filed on 1987-12-23

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1330
  • Page 1331
  • Page 1332
  • Page 1333
  • Page 1334
  • Page 1335
  • Page 1336
  • Page 1337
  • Page 1338
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health